Please use this identifier to cite or link to this item:
Title: Fragment-based drug discovery and mechanistic studies of human thymidylate synthase
Authors: Chen, Dan
Keywords: DRNTU::Science::Biological sciences::Molecular biology
Issue Date: 2016
Publisher: Nanyang Technological University
Abstract: Human thymidylate synthase (hTS) is the sole enzyme responsible for de novo biosynthesis of dTMP and is vital to cell proliferation and survival. Inhibition of hTS has been explored and found to be effective in cancer chemotherapy, while the efficacy is limited by drug resistance. Herein fragment screening is applied to hTS to identify novel start point for drug design. Four types of hits are found, of which two are progressed to structure- and biophysics-driven drug design due to novel binding modes in the active site. The elaborated compounds show significant improvements in affinities and open new avenues for development of hTS inhibitors to overcome drug resistance. Meanwhile, another type of hit reveals a potential allosteric site of hTS possibly involved in regulating overexpression-induced drug resistance to hTS inhibitors.
DOI: 10.32657/10356/65932
Rights: This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).
Fulltext Permission: embargo_20220731
Fulltext Availability: With Fulltext
Appears in Collections:SBS Theses

Files in This Item:
File Description SizeFormat 
Thesis_Chen Dan.pdf
  Until 2022-07-31
Main article17.26 MBAdobe PDFUnder embargo until Jul 31, 2022

Google ScholarTM




Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.